KAITLIN MORAN: Open Payments
NPI 1912585134 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,309 in 49 payments from 27 companies in 2025. Trend: 2023 $283 · 2024 $967 · 2025 $1,309
Food & beverage: $1,217Education: $92
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 14 | $414 |
| SEAGEN INC. | 1 | $92 |
| Merck Sharp & Dohme LLC | 3 | $73 |
| AstraZeneca Pharmaceuticals LP | 2 | $62 |
| GENZYME CORPORATION | 2 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $54 |
| Daiichi Sankyo Inc. | 2 | $52 |
| JAZZ PHARMACEUTICALS INC. | 2 | $48 |
| Celgene Corporation | 2 | $44 |
| Janssen Biotech, Inc. | 2 | $42 |
Products named: KISQALI, Fabhalta, PLUVICTO, KEYTRUDA, SARCLISA, Enhertu, ZEPZELCA, REBLOZYL.
Industry payments across TN — which companies pay providers there.
